Phabuilder Biotechnology Co., Ltd. is a pioneer in cutting-edge synthetic biology that embraces the ethos "From Microbes to the Future." With two decades of PHA research and advancements in Halomonas generations, Phabuilder's avant-garde "Super Cell Factory" emerges via the "Next Generation Industrial Biotechnology (NGIB)" platform, yielding 30+ eco-friendly products from medical to daily essentials, powered by a new-gen intelligent production line in Beijing and several high-capacity Hubei bases underway. Having secured $100M USD from investors like CNPC Kunlun and Sequoia, Phabuilder shapes a fresh era of advances in eco-friendly synthetic biology, promising a future defined by innovation and sustainability.